EPHA3 (EPH receptor A3) is upregulated in a variety of human cancers including prostate cancer [48], and stimulates prostate cancer proliferation and survival in LNCaP cells and mouse xenograft models [48]. The gene discussed is EPHA3; the disease is prostate carcinoma.